BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15665109)

  • 1. Anomalous megakaryocytopoiesis in mice with mutations in the c-Myb gene.
    Metcalf D; Carpinelli MR; Hyland C; Mifsud S; Dirago L; Nicola NA; Hilton DJ; Alexander WS
    Blood; 2005 May; 105(9):3480-7. PubMed ID: 15665109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational inhibition of c-Myb or p300 ameliorates treatment-induced thrombocytopenia.
    Hilton DJ; Kile BT; Alexander WS
    Blood; 2009 May; 113(22):5599-604. PubMed ID: 19252138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Megakaryocytopoiesis and granulopoiesis in W/Wv mice: comparisons between bone marrow and spleen.
    Petursson SR; Chervenick PA
    J Lab Clin Med; 1987 Dec; 110(6):773-83. PubMed ID: 3681118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-Myb and GATA-1 alternate dominant roles during megakaryocyte differentiation.
    GarcĂ­a P; Berlanga O; Vegiopoulos A; Vyas P; Frampton J
    J Thromb Haemost; 2011 Aug; 9(8):1572-81. PubMed ID: 21668739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine prolactin-like protein E synergizes with human thrombopoietin to stimulate expansion of human megakaryocytes and their precursors.
    Lefebvre P; Lin J; Linzer DI; Cohen I
    Exp Hematol; 2001 Jan; 29(1):51-8. PubMed ID: 11164105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effect of erythropoietin and GM-CSF on megakaryocytopoiesis from primitive bone marrow cells in serum-free conditions.
    Cardier JE; Erickson-Miller CL; Murphy MJ
    Stem Cells; 1997; 15(4):286-90. PubMed ID: 9253112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of thrombopoietic-stimulatory factor and spleen cell-conditioned medium on megakaryocytopoiesis in a short-term bone marrow liquid culture system.
    Petursson SR; Chervenick PA
    Exp Hematol; 1988 Sep; 16(8):660-6. PubMed ID: 3261250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmentation of megakaryocytopoiesis within the hematopoietic microenvironment of human granulocyte colony-stimulating factor transgenic mice.
    Fujita T; Yamada T; Hashiguchi A; Fukushima S; Kondoh K; Fujimoto J; Hata J
    Exp Hematol; 2001 Aug; 29(8):1010-8. PubMed ID: 11495707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombopoietin expands erythroid, granulocyte-macrophage, and megakaryocytic progenitor cells in normal and myelosuppressed mice.
    Kaushansky K; Lin N; Grossmann A; Humes J; Sprugel KH; Broudy VC
    Exp Hematol; 1996 Feb; 24(2):265-9. PubMed ID: 8641351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Megakaryocytopoiesis in vitro: from the stem cells' perspective.
    Cardier JE; Foster DC; Lok S; Jacobsen SE; Murphy MJ
    Stem Cells; 1996; 14 Suppl 1():163-72. PubMed ID: 11012217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Myc-mediated control of cell fate in megakaryocyte-erythrocyte progenitors.
    Guo Y; Niu C; Breslin P; Tang M; Zhang S; Wei W; Kini AR; Paner GP; Alkan S; Morris SW; Diaz M; Stiff PJ; Zhang J
    Blood; 2009 Sep; 114(10):2097-106. PubMed ID: 19372257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incomplete restoration of Mpl expression in the mpl-/- mouse produces partial correction of the stem cell-repopulating defect and paradoxical thrombocytosis.
    Lannutti BJ; Epp A; Roy J; Chen J; Josephson NC
    Blood; 2009 Feb; 113(8):1778-85. PubMed ID: 18796624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Point mutation in the gene encoding p300 suppresses thrombocytopenia in Mpl-/- mice.
    Kauppi M; Murphy JM; de Graaf CA; Hyland CD; Greig KT; Metcalf D; Hilton AA; Nicola NA; Kile BT; Hilton DJ; Alexander WS
    Blood; 2008 Oct; 112(8):3148-53. PubMed ID: 18684867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte-macrophage colony-stimulating factor is not responsible for residual thrombopoiesis in mpl null mice.
    Scott CL; Robb L; Mansfield R; Alexander WS; Begley CG
    Exp Hematol; 2000 Sep; 28(9):1001-7. PubMed ID: 11008012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of megakaryocyte spleen colony-forming units by response to 5-fluorouracil and by unit gravity sedimentation.
    Thean LE; Hodgson GS; Bertoncello I; Radley JM
    Blood; 1983 Oct; 62(4):896-901. PubMed ID: 6882927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in the regulation of megakaryocytopoiesis in the murine bone marrow and spleen.
    Long MW; Williams N
    Leuk Res; 1982; 6(5):721-8. PubMed ID: 7154708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous infusion of interleukin-6 in sublethally irradiated mice accelerates platelet reconstitution and the recovery of myeloid but not of megakaryocytic progenitor cells in bone marrow.
    Laterveer L; van Damme J; Willemze R; Fibbe WE
    Exp Hematol; 1993 Dec; 21(13):1621-7. PubMed ID: 8243564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of 5-fluorouracil on hematopoiesis: studies of murine megakaryocyte-CFC, granulocyte-macrophage-CFC, and peripheral blood cell levels.
    Yeager AM; Levin J; Levin FC
    Exp Hematol; 1983 Nov; 11(10):944-52. PubMed ID: 6662215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic effects on erythropoiesis, thrombopoiesis, and stem cell competitiveness in mice deficient in thrombopoietin and steel factor receptors.
    Antonchuk J; Hyland CD; Hilton DJ; Alexander WS
    Blood; 2004 Sep; 104(5):1306-13. PubMed ID: 15138166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex vivo expansion of megakaryocyte precursors by preincubation of marrow allografts with interleukin-3 and granulocyte-macrophage colony-stimulating factor in vitro.
    Nagler A; Eldor A; Naparstek E; Mumcuoglu M; Slavin S; Deutsch VR
    Exp Hematol; 1995 Nov; 23(12):1268-74. PubMed ID: 7589281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.